Table 1 Prevalence of the metabolic syndrome in patients with rheumatoid arthritis and controls.
| Age group (years) | Study population | Women | Men | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | % | p Value* | n | % | p Value* | n | % | p Value* | ||
| <60 | RA | 20/58 | 34.5 | 0.7 | 4/10 | 40 | 0.2 | 24/68 | 35.3 | 0.4 |
| Controls | 37/116 | 31.9 | 3/18 | 16.7 | 40/134 | 29.9 | ||||
| 60–70 | RA | 27/53 | 50.9 | 0.2 | 9/25 | 36 | 1 | 36/78 | 46.2 | 0.3 |
| Controls | 42/106 | 39.6 | 19/52 | 36.5 | 61/158 | 38.6 | ||||
| >70 | RA | 20/36 | 55.6 | 0.5 | 8/18 | 44.4 | 0.7 | 28/54 | 51.9 | 0.4 |
| Controls | 45/72 | 62.5 | 18/36 | 50 | 63/108 | 58.3 | ||||
| Total | RA | 67/147 | 45.6 | 0.5 | 21/53 | 39.6 | 0.8 | 88/200 | 44 | 0.5 |
| Controls | 124/294 | 42.2 | 40/106 | 37.7 | 164/400 | 41 | ||||
RA, rheumatoid arthritis.
*Difference between patients with RA and controls.